A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder

被引：0
|
作者：
Wade, A. [1 ]
Gembert, K. [2 ]
Florea, I. [2 ]
机构：
[1] CPS Clin Res Ctr, Glasgow, Lanark, Scotland
[2] H Lundbeck & Co AS, Copenhagen, Denmark
来源：
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE | 2007年 / 11卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：339 / 339
页数：1
相关论文
共 50 条
  • [31] A pharmacoeconomic comparison of escitalopram and duloxetine in treatment of major depressive disorder (MDD) in the United Kingdom
    Wade, A. G.
    Fernandez, J. L.
    Francois, C.
    Hansen, K.
    Despiegel, N.
    Danchenko, N.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A306 - A306
  • [32] A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder
    Armstrong, Edward P.
    Malone, Daniel C.
    Erder, M. Haim
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (04) : 1115 - 1121
  • [33] EFFICACY OF DULOXETINE ON FUNCTIONAL IMPAIRMENT IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Sheehan, David V.
    Meyers, Adam L.
    Ahl, Jonna
    Prakash, Apurva
    Oakes, Tina Marie Myers
    Kelin, Katarina
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2011, 45 : A63 - A63
  • [34] The efficacy of citalopram or escitalopram in patients with asthma and major depressive disorder
    Agarwal, Catherine D.
    Palka, Jayme M.
    Gajewski, Alexander J.
    Khan, David A.
    Brown, Sherwood
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (03) : 374 - 382
  • [35] Effect of citalopram versus escitalopram on quality of life in the treatment of the acute phase of major depressive disorder: a comparative, open-label study
    Aydemir, Omer
    Ergun, Hakan
    Kesebir, Sermin
    Soygur, Haldun
    Tulunay, Cankat
    [J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 21 (03): : 210 - 218
  • [36] Efficacy and Safety of Escitalopram in the Treatment of Major Depressive Disorder in Chinese Patients: A Meta-Analysis Study
    Gou, Mingyang
    [J]. 2019 ASIA-PACIFIC CONFERENCE ON CLINICAL MEDICINE AND PUBLIC HEALTH (CMPH 2019), 2019, : 83 - 88
  • [37] COMPARATIVE ANALYSIS OF THE EFFICACY AND SAFETY OF ESCITALOPRAM WITH SERTRALINE AND VENLAFAXINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
    Walczak, J.
    Malysiak, S.
    Rowinska, M.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A107 - A107
  • [38] Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features
    Mallinckrodt, Craig H.
    Watkin, John G.
    Liu, Chaofeng
    Wohlreich, Madelaine M.
    Raskin, Joel
    [J]. BMC PSYCHIATRY, 2005, 5 (1)
  • [39] Duloxetine in the treatment of major depressive disorder: A comparison of efficacy in patients with and without melancholic features
    Mallinckrodt, CH
    Watkin, JG
    Liu, C
    Wohlreich, MM
    Raskin, J
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S175 - S175
  • [40] Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features
    Craig H Mallinckrodt
    John G Watkin
    Chaofeng Liu
    Madelaine M Wohlreich
    Joel Raskin
    [J]. BMC Psychiatry, 5
12345